Drug Development

14 October 2022

Biodata and AI in Drug Discovery – October 2022

Early clinical trial data supports amivantamab against a rare lung cancer mutation

Brain mapping identifies therapeutic targets for neuropsychiatric symptoms

Predicting FDA approval using artificial intelligence

Outer product-based convolutional neural network to predict the outcome of clinical trials

Cell death detection using a convolutional neural network (CNN) aids drug development

The role of artificial intelligence (AI) and big data in drug discovery

Are ‘virtual patients’ the future of clinical trials?

New database of transcriptional regulators for cancer drug development

Meta-analysis of transcriptomic data from Huntington’s disease patients